title: Clinical practice. Glucocorticoid-induced bone disease.
authors: Division of Endocrinology and Metabolism, the Center for Osteoporosis and Metabolic Bone Diseases, the Department of Internal Medicine, and the Central Arkansas Veterans Healthcare System at the University of Arkansas for Medical Sciences, Little Rock, Little Rock, AR 72205-7199, USA. weinsteinroberts@uams.edu
authors: Robert S
authors: RS
authors: Weinstein
mesh_terms: D001249:Asthma / Q000188:drug therapy; D015519:Bone Density; D001847:Bone Diseases; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011241:Prednisone / Q000009:adverse effects; D012307:Risk Factors; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D004164:Diphosphonates; D005938:Glucocorticoids; D014807:Vitamin D; D002118:Calcium; D011241:Prednisone